ADNI Data

Access to ADNI Samples

Any scientist may apply for biomarker samples collected by ADNI. To fully understand the number of subjects and sample collection, refer to the ADNI Protocol, and Biofluids section of the ADNI procedures manual.

How to Apply
Applications will follow the format of NIH R01 limited to 5 pages.  Only manuscripts accepted for publication, published manuscripts, and submitted grants will be considered as appendix material.

Applications should be sent to the RARC committee (tmontine@u.washington.edu)
View for detailed information on the NIH R01. Include sections on Hypothesis and Specific Aims, Background and Significance, Preliminary Studies, and Experimental Plan. Please limit to 5 pages, and follow NIH guidelines for a R01 application.

Applications should be completed and sent to tmontine@u.washington.edu.

With questions about completing the form please contact the Resource Allocation Review Committee at tmontine@u.washington.edu.
Policy and Procedures - RARC
Alzheimer’s Disease Neuroimaging Initiative (ADNI) Resource Allocation Review Committee (RARC) Policy and Procedures Statement (updated August 2012)
The Policy and Procedures of RARC are subject to change as ADNI progresses and further experience is gained.

One of the goals of ADNI is the collection of biospecimens, including blood, urine, and cerebrospinal fluid (CSF) from participants. An accounting of the biospecimens available through ADNI will be maintained on the ADNI website. Several analyses of general interest (homocysteine, species of isoprostanes, tau and Aβ) will be performed by the ADNI Biomarkers Core, with results made available on the ADNI web site as soon as the laboratory analyses are complete.

Interested investigators, whether associated with an ADNI site or not, are encouraged to apply for use of this limited resource. However, use of ADNI samples for technology development or comparisons among different technologies is not recommended for well established analytes unless there is preliminary data showing clearly superior performance.

Please note it is ADNI policy that if your application to obtain ADNI samples is approved by the RARC, ADNI will send you these samples with a code number which does not permit you to link the samples to ADNI data. Once you have finished your analyses, and performed QC, it also is ADNI policy that you send the results to Michael Donohue at ADCS and he will upload the results to the ADNI database. Once these data are in the ADNI database you (and others) will be able to analyze the data and relate the results to diagnosis and other features.